99 Results

People

  1. Kris
    Kris
  2. Chaft
    Chaft
  3. Rusch
    Rusch
  4. Bajorin
    Bajorin
  5. Gonen
    Gonen
  6. Dang
    Dang
  7. Jones
    Jones
  8. Postow
    Postow
  9. Baselga
    Baselga
  10. Bochner
    Bochner

Groups

  1. Department of Medicine (64)
  2. Solid Tumor Oncology Division (63)
  3. Surgery (41)
  4. Thoracic Oncology (23)
  5. Survivorship Research (20)
  6. Department of Pathology and Laboratory Medicine (15)
  7. Genitourinary Oncology Service (13)
  8. Melanoma Disease Management Team (11)
  9. Center for Pancreatic Cancer Research (10)
  10. Epidemiology and Biostatistics (10)
  1. "neoadjuvant"
Formats
  1. Journal Article (57)
  2. Review (17)
  3. Meeting Abstract (12)
  4. Editorial (8)
  5. Book Section (3)
  6. Guidelines (1)
  7. Miscellaneous (1)
Groups
  1. Department of Medicine (64)
  2. Solid Tumor Oncology Division (63)
  3. Surgery (41)
  4. Thoracic Oncology (23)
  5. Survivorship Research (20)
  6. Department of Pathology and Laboratory Medicine (15)

More Groups

People
  1. Jamie Chaft (16)
  2. Mark Kris (12)
  3. Valerie Rusch (9)
  4. Dean Bajorin (5)
  5. Mithat Gonen (5)
  6. Chau Dang (4)

More People

Years
  1. 2025 (2)
  2. 2024 (9)
  3. 2023 (9)
  4. 2022 (7)
  5. 2021 (13)
  6. 2020 (7)

More Years

Publications
  1. Journal of Thoracic Oncology (14)
  2. Annals of Oncology (7)
  3. BJU International (4)
  4. Cancer (4)
  5. Journal of Translational Medicine (4)
  6. European Journal of Cancer (3)

More Publications

Publishers
  1. Elsevier Inc. (25)
  2. Wiley Blackwell (14)
  3. Oxford University Press (10)
  4. Springer (8)
  5. Lippincott Williams & Wilkins (7)
  6. Biomed Central Ltd (4)

More Publishers

Results (99)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rationale and outcomes for neoadjuvant immunotherapy in urothelial carcinoma of the bladder
    Review

    Rouanne, M.; Bajorin, D. F.; Hannan, R.; Galsky, M. D.; Williams, S. B.; Necchi, A.; Sharma, P.; Powles, T.
    European Urology Oncology (2020)

    Fulltext@MSK | Save
  • Perioperative considerations for neoadjuvant immunotherapy in non–small cell lung cancer
    Editorial

    Stiles, B. M.; Sepesi, B.; Broderick, S. R.; Bott, M. J.
    Journal of Thoracic and Cardiovascular Surgery (2020)

    Fulltext@MSK | Save
  • TBCRC 030: A phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: Evaluating the homologous recombination deficiency (HRD) biomarker
    Journal Article

    Mayer, E. L.; Abramson, V.; Jankowitz, R.; Falkson, C.; Marcom, P. K.; Traina, T.; Carey, L.; Rimawi, M.; Specht, J.; Miller, K.; more...
    Annals of Oncology (2020)

    Fulltext@MSK | Save
  • Thymic malignancy—Updates in staging and management
    Review

    Rappaport, J. M. P.; Huang, J.; Ahmad, U.
    Surgical Oncology Clinics of North America (2020)

    Fulltext@MSK | Save
  • Perspectives in melanoma: Meeting report from the "Melanoma Bridge" (December 5th-7th, 2019, Naples, Italy)
    Editorial

    Ascierto, P. A.; Puzanov, I.; Agarwala, S. S.; Blank, C.; Carvajal, R. D.; Demaria, S.; Dummer, R.; Ernstoff, M.; Ferrone, S.; Fox, B. A.; more...
    Journal of Translational Medicine (2020)

    Fulltext@MSK | Save
  • The Great Debate at "Melanoma Bridge", Naples, December 7th, 2019
    Miscellaneous

    Ascierto, P. A.; Agarwala, S. S.; Eggermont, A.; Gershenwald, J. E.; Grob, J. J.; Hamid, O.; Michielin, O.; Postow, M.; Puzanov, I.; Zarour, H. M.; more...
    Journal of Translational Medicine (2020)

    Fulltext@MSK | Save
  • Neoadjuvant treatment in patients with resectable and borderline resectable pancreatic cancer
    Review

    Janssen, Q. P.; O'Reilly, E. M.; van Eijck, C. H. J.; Koerkamp, B. G.
    Frontiers in Oncology (2020)

    Fulltext@MSK | Save
  • Neoadjuvant treatment in breast cancer
    Book Section

    Wang, R.; Dang, C.
    In Urban, C.; Rietjens, M.; El-Tamer, M.; Sacchini, V. S. (Eds.) Oncoplastic and Reconstructive Breast Surgery. 2nd ed (2019)

    Fulltext@MSK | Save
  • Surgical outcomes of a multicenter phase II trial of neoadjuvant atezolizumab in resectable stages IB-IIIB NSCLC: Update on LCMC3 clinical trial
    Meeting Abstract

    Lee, J.; Chaft, J.; Nicholas, A.; Patterson, G.; Waqar, S.; Toloza, E.; Haura, E.; Raz, D.; Reckamp, K.; Merritt, R.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • The current role for adjuvant and neoadjuvant therapy in renal cell cancer
    Review

    Gleeson, J. P.; Motzer, R. J.; Lee, C. H.
    Current Opinion in Urology (2019)

    Fulltext@MSK | Save